News
The company has collected more than 10.5 billion nights of sleep data over the years, which helped them to provide insights on Singaporean users.
The Venu watch includes sleep tracking, respiration tracking, abnormal heart rate alerts and menstrual cycle tracking.
This is the company's second platform-focused expansion within the last year.
The software combines ECG readings with artificial intelligence to deliver personalized workout guidance.
The pair will be targeting patients with asymptomatic or silent atrial fibrillation.
The round was co-led by New Leaf Venture Partners and Eclipse Ventures.
An interview with David Grauer, Senior Vice President, Health Catalyst.
The platform will let users request birth control, get a UTI prescription and schedule an in-person appointment.
Also: Women's health apps launch PCOS screening tools; uBiome files for bankruptcy.
WP Global Partners led the round with participation from City Light Capital, Nimble Ventures, LinkedIn CEO Jeff Weiner, Khosla Ventures, Kaiser Permanente Ventures and Kapor Capital.